Regie Lyn Santos-Cortez
Concepts (381)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
---|
Otitis Media | 17 | 2025 | 163 | 9.760 |
Why?
| Hearing Loss | 26 | 2023 | 208 | 5.450 |
Why?
| Genes, Recessive | 27 | 2021 | 75 | 3.330 |
Why?
| Mutation, Missense | 16 | 2024 | 319 | 2.990 |
Why?
| Pedigree | 54 | 2025 | 491 | 2.930 |
Why?
| Microbiota | 10 | 2023 | 724 | 2.550 |
Why?
| Deafness | 7 | 2023 | 79 | 2.530 |
Why?
| Genetic Variation | 12 | 2025 | 935 | 2.500 |
Why?
| alpha-Macroglobulins | 5 | 2023 | 25 | 2.390 |
Why?
| Genetic Predisposition to Disease | 25 | 2025 | 2273 | 2.280 |
Why?
| Ear, Middle | 8 | 2024 | 93 | 2.270 |
Why?
| Mutation | 27 | 2023 | 3679 | 1.880 |
Why?
| Consanguinity | 21 | 2024 | 47 | 1.400 |
Why?
| Fucosyltransferases | 2 | 2022 | 33 | 1.370 |
Why?
| Cochlear Implantation | 3 | 2021 | 86 | 1.310 |
Why?
| Sequence Analysis, DNA | 16 | 2020 | 778 | 1.230 |
Why?
| Cochlear Implants | 3 | 2020 | 103 | 1.180 |
Why?
| Membrane Proteins | 9 | 2021 | 1102 | 1.140 |
Why?
| RNA, Ribosomal, 16S | 5 | 2023 | 521 | 1.110 |
Why?
| Exome | 17 | 2023 | 219 | 1.100 |
Why?
| Gene Frequency | 8 | 2019 | 503 | 0.950 |
Why?
| Palatine Tonsil | 1 | 2024 | 45 | 0.920 |
Why?
| Nasopharynx | 2 | 2022 | 67 | 0.920 |
Why?
| Herpesvirus 4, Human | 1 | 2024 | 153 | 0.870 |
Why?
| Pakistan | 17 | 2024 | 75 | 0.870 |
Why?
| Otitis Media, Suppurative | 2 | 2024 | 4 | 0.850 |
Why?
| Epstein-Barr Virus Infections | 1 | 2024 | 93 | 0.850 |
Why?
| Intellectual Disability | 3 | 2023 | 153 | 0.840 |
Why?
| Aortic Aneurysm, Thoracic | 8 | 2016 | 128 | 0.820 |
Why?
| Alleles | 8 | 2019 | 847 | 0.820 |
Why?
| Meniere Disease | 1 | 2023 | 31 | 0.810 |
Why?
| Cholesteatoma | 1 | 2022 | 11 | 0.780 |
Why?
| Migraine Disorders | 1 | 2023 | 91 | 0.760 |
Why?
| Cadherin Related Proteins | 1 | 2021 | 12 | 0.750 |
Why?
| Haemophilus Infections | 1 | 2022 | 40 | 0.750 |
Why?
| Genotype | 17 | 2023 | 1835 | 0.740 |
Why?
| Connexins | 6 | 2016 | 53 | 0.740 |
Why?
| Child | 25 | 2025 | 20860 | 0.730 |
Why?
| Down-Regulation | 2 | 2024 | 639 | 0.730 |
Why?
| Mentoring | 1 | 2023 | 120 | 0.730 |
Why?
| Membrane Transport Proteins | 4 | 2017 | 148 | 0.720 |
Why?
| Temporal Bone | 1 | 2021 | 51 | 0.710 |
Why?
| Sleep Apnea, Obstructive | 1 | 2024 | 238 | 0.710 |
Why?
| Serine Peptidase Inhibitor Kazal-Type 5 | 1 | 2020 | 3 | 0.710 |
Why?
| Plasminogen | 1 | 2020 | 31 | 0.700 |
Why?
| Male | 64 | 2025 | 63248 | 0.700 |
Why?
| Scoliosis | 1 | 2023 | 205 | 0.690 |
Why?
| Humans | 84 | 2025 | 129079 | 0.680 |
Why?
| Child, Preschool | 15 | 2025 | 10462 | 0.670 |
Why?
| Otitis Media with Effusion | 1 | 2019 | 23 | 0.660 |
Why?
| ABO Blood-Group System | 1 | 2019 | 40 | 0.660 |
Why?
| Female | 63 | 2025 | 68274 | 0.650 |
Why?
| Philippines | 5 | 2019 | 50 | 0.620 |
Why?
| Gene Regulatory Networks | 1 | 2021 | 279 | 0.620 |
Why?
| Genetic Markers | 3 | 2018 | 336 | 0.610 |
Why?
| Mice | 15 | 2025 | 16583 | 0.610 |
Why?
| Mice, Knockout | 3 | 2024 | 2774 | 0.610 |
Why?
| Acid Ceramidase | 1 | 2017 | 1 | 0.580 |
Why?
| Keloid | 1 | 2017 | 7 | 0.570 |
Why?
| Albinism, Oculocutaneous | 1 | 2017 | 6 | 0.560 |
Why?
| Ear, Inner | 3 | 2016 | 44 | 0.560 |
Why?
| Homozygote | 9 | 2018 | 192 | 0.550 |
Why?
| Genes, Duplicate | 1 | 2016 | 4 | 0.550 |
Why?
| Down Syndrome | 1 | 2023 | 454 | 0.540 |
Why?
| Receptors, Lysosphingolipid | 1 | 2016 | 14 | 0.510 |
Why?
| Neurodevelopmental Disorders | 1 | 2018 | 153 | 0.510 |
Why?
| Hearing Loss, Sensorineural | 4 | 2021 | 56 | 0.510 |
Why?
| Animals | 20 | 2025 | 34708 | 0.510 |
Why?
| Genetic Linkage | 13 | 2018 | 299 | 0.510 |
Why?
| Haplotypes | 8 | 2019 | 473 | 0.490 |
Why?
| Hair Cells, Auditory | 2 | 2021 | 41 | 0.480 |
Why?
| Gene Duplication | 1 | 2015 | 67 | 0.480 |
Why?
| DNA, Bacterial | 1 | 2016 | 324 | 0.480 |
Why?
| Disease Models, Animal | 2 | 2024 | 3999 | 0.460 |
Why?
| Phenotype | 14 | 2021 | 3062 | 0.440 |
Why?
| Adolescent | 20 | 2024 | 20241 | 0.440 |
Why?
| Adenylyl Cyclases | 1 | 2014 | 83 | 0.440 |
Why?
| Lysine-tRNA Ligase | 1 | 2013 | 2 | 0.430 |
Why?
| Lod Score | 11 | 2016 | 66 | 0.420 |
Why?
| Cyclic AMP | 1 | 2014 | 230 | 0.420 |
Why?
| Myosins | 3 | 2021 | 133 | 0.420 |
Why?
| Genetic Loci | 6 | 2014 | 274 | 0.400 |
Why?
| Gene Expression Profiling | 1 | 2019 | 1696 | 0.390 |
Why?
| Chromosomes, Human, Pair 19 | 2 | 2016 | 24 | 0.390 |
Why?
| Environmental Exposure | 1 | 2016 | 479 | 0.380 |
Why?
| Retinitis Pigmentosa | 2 | 2023 | 20 | 0.370 |
Why?
| Adult | 23 | 2024 | 35423 | 0.370 |
Why?
| Otoscopy | 2 | 2023 | 8 | 0.340 |
Why?
| Chromosomes, Human, Pair 4 | 2 | 2006 | 29 | 0.330 |
Why?
| Finland | 2 | 2019 | 91 | 0.320 |
Why?
| Polymorphism, Single Nucleotide | 7 | 2025 | 2071 | 0.320 |
Why?
| Polydactyly | 2 | 2019 | 6 | 0.320 |
Why?
| Codon, Nonsense | 4 | 2018 | 40 | 0.320 |
Why?
| Genetic Association Studies | 6 | 2019 | 356 | 0.320 |
Why?
| Family Health | 6 | 2019 | 199 | 0.310 |
Why?
| Toes | 2 | 2019 | 27 | 0.310 |
Why?
| Amino Acid Sequence | 9 | 2020 | 2050 | 0.300 |
Why?
| Fingers | 2 | 2019 | 87 | 0.300 |
Why?
| Ichthyosiform Erythroderma, Congenital | 3 | 2017 | 6 | 0.290 |
Why?
| Genes, Dominant | 2 | 2011 | 92 | 0.280 |
Why?
| Sequence Analysis, RNA | 2 | 2020 | 422 | 0.280 |
Why?
| Connexin 26 | 5 | 2014 | 8 | 0.280 |
Why?
| Mice, Inbred C57BL | 6 | 2021 | 5282 | 0.270 |
Why?
| Genomics | 3 | 2020 | 716 | 0.260 |
Why?
| COS Cells | 2 | 2018 | 185 | 0.260 |
Why?
| Frameshift Mutation | 3 | 2015 | 32 | 0.240 |
Why?
| Exons | 5 | 2018 | 332 | 0.240 |
Why?
| Infant | 7 | 2021 | 8997 | 0.240 |
Why?
| Molecular Sequence Data | 7 | 2016 | 2846 | 0.240 |
Why?
| Case-Control Studies | 4 | 2025 | 3336 | 0.240 |
Why?
| Molecular Epidemiology | 1 | 2005 | 62 | 0.230 |
Why?
| Bacteria | 2 | 2022 | 812 | 0.230 |
Why?
| Serine Endopeptidases | 2 | 2018 | 113 | 0.230 |
Why?
| HEK293 Cells | 4 | 2023 | 674 | 0.230 |
Why?
| Fasting | 1 | 2006 | 265 | 0.220 |
Why?
| Continuous Positive Airway Pressure | 1 | 2024 | 69 | 0.220 |
Why?
| Models, Molecular | 4 | 2016 | 1480 | 0.210 |
Why?
| Cochlea | 2 | 2015 | 100 | 0.210 |
Why?
| Intracranial Aneurysm | 2 | 2016 | 95 | 0.210 |
Why?
| Zebrafish | 4 | 2016 | 448 | 0.210 |
Why?
| Vertigo | 1 | 2023 | 38 | 0.210 |
Why?
| Chromosome Mapping | 8 | 2019 | 505 | 0.210 |
Why?
| Faculty | 1 | 2023 | 132 | 0.200 |
Why?
| High-Throughput Nucleotide Sequencing | 5 | 2016 | 485 | 0.190 |
Why?
| Extracellular Matrix Proteins | 1 | 2023 | 144 | 0.190 |
Why?
| ADAMTS1 Protein | 1 | 2021 | 2 | 0.190 |
Why?
| Carboxy-Lyases | 1 | 2021 | 8 | 0.190 |
Why?
| Mentors | 1 | 2023 | 174 | 0.190 |
Why?
| RNA Splice Sites | 2 | 2018 | 40 | 0.190 |
Why?
| Haemophilus influenzae | 1 | 2022 | 63 | 0.190 |
Why?
| Intracellular Signaling Peptides and Proteins | 2 | 2019 | 422 | 0.180 |
Why?
| Phosphoric Diester Hydrolases | 1 | 2021 | 46 | 0.180 |
Why?
| Oncogene Proteins | 1 | 2021 | 54 | 0.180 |
Why?
| Ear, External | 1 | 2020 | 24 | 0.170 |
Why?
| Base Sequence | 2 | 2015 | 2157 | 0.170 |
Why?
| DNA Demethylation | 1 | 2020 | 1 | 0.170 |
Why?
| Mouth | 1 | 2020 | 81 | 0.170 |
Why?
| Young Adult | 9 | 2020 | 12310 | 0.170 |
Why?
| Dioxygenases | 1 | 2020 | 29 | 0.170 |
Why?
| Chronic Disease | 2 | 2024 | 1717 | 0.160 |
Why?
| Lipoxygenase | 2 | 2017 | 14 | 0.160 |
Why?
| Ichthyosis, Lamellar | 2 | 2017 | 9 | 0.160 |
Why?
| Feasibility Studies | 1 | 2023 | 860 | 0.160 |
Why?
| Nerve Tissue Proteins | 2 | 2021 | 570 | 0.160 |
Why?
| Saliva | 1 | 2020 | 204 | 0.160 |
Why?
| Protein Conformation | 3 | 2020 | 853 | 0.160 |
Why?
| Ciliopathies | 1 | 2018 | 6 | 0.160 |
Why?
| Acute Disease | 2 | 2019 | 978 | 0.160 |
Why?
| Chromosome Segregation | 1 | 2018 | 40 | 0.150 |
Why?
| Tumor Suppressor Proteins | 1 | 2021 | 313 | 0.150 |
Why?
| Arthrogryposis | 2 | 2015 | 7 | 0.150 |
Why?
| Hypotrichosis | 1 | 2018 | 1 | 0.150 |
Why?
| Middle Aged | 11 | 2020 | 31024 | 0.150 |
Why?
| Genetic Diseases, Inborn | 1 | 2018 | 38 | 0.150 |
Why?
| Ichthyosis | 1 | 2018 | 12 | 0.150 |
Why?
| Disease Susceptibility | 1 | 2020 | 338 | 0.150 |
Why?
| RNA Splicing Factors | 1 | 2018 | 50 | 0.150 |
Why?
| Nails, Malformed | 1 | 2017 | 5 | 0.150 |
Why?
| Skin Diseases, Genetic | 1 | 2017 | 11 | 0.150 |
Why?
| DEAD-box RNA Helicases | 1 | 2018 | 61 | 0.150 |
Why?
| 3' Untranslated Regions | 1 | 2018 | 137 | 0.150 |
Why?
| Polymorphism, Genetic | 3 | 2005 | 642 | 0.140 |
Why?
| Cytoskeletal Proteins | 2 | 2015 | 141 | 0.140 |
Why?
| Family | 2 | 2018 | 651 | 0.140 |
Why?
| Rare Diseases | 1 | 2017 | 102 | 0.140 |
Why?
| Optic Atrophy | 1 | 2016 | 10 | 0.140 |
Why?
| Linkage Disequilibrium | 2 | 2016 | 255 | 0.140 |
Why?
| Developmental Disabilities | 1 | 2020 | 254 | 0.140 |
Why?
| Oxidoreductases Acting on CH-CH Group Donors | 1 | 2016 | 23 | 0.130 |
Why?
| Dystonic Disorders | 1 | 2016 | 23 | 0.130 |
Why?
| Recurrence | 1 | 2019 | 1013 | 0.130 |
Why?
| Population Groups | 1 | 2016 | 60 | 0.130 |
Why?
| Trichothiodystrophy Syndromes | 1 | 2016 | 1 | 0.130 |
Why?
| Marfan Syndrome | 2 | 2016 | 42 | 0.130 |
Why?
| Fibrillin-1 | 1 | 2016 | 5 | 0.130 |
Why?
| Protein-Lysine 6-Oxidase | 1 | 2016 | 8 | 0.130 |
Why?
| Integrin beta Chains | 1 | 2015 | 8 | 0.130 |
Why?
| Alopecia | 1 | 2015 | 28 | 0.130 |
Why?
| Blood Glucose | 1 | 2006 | 2088 | 0.130 |
Why?
| Autistic Disorder | 2 | 2020 | 184 | 0.130 |
Why?
| Tooth Abnormalities | 1 | 2015 | 14 | 0.130 |
Why?
| Precision Medicine | 1 | 2019 | 386 | 0.130 |
Why?
| Sphingosine | 1 | 2016 | 39 | 0.130 |
Why?
| Keratins, Type I | 1 | 2015 | 1 | 0.130 |
Why?
| Hair Diseases | 1 | 2015 | 9 | 0.120 |
Why?
| Activating Transcription Factor 6 | 1 | 2015 | 16 | 0.120 |
Why?
| Color Vision Defects | 1 | 2015 | 7 | 0.120 |
Why?
| Coatomer Protein | 1 | 2015 | 3 | 0.120 |
Why?
| Lysophospholipids | 1 | 2016 | 71 | 0.120 |
Why?
| Lipase | 1 | 2015 | 63 | 0.120 |
Why?
| Mitral Valve Insufficiency | 1 | 2016 | 79 | 0.120 |
Why?
| Cohort Studies | 4 | 2019 | 5400 | 0.120 |
Why?
| Transcriptome | 1 | 2021 | 875 | 0.120 |
Why?
| Methionine Adenosyltransferase | 1 | 2014 | 10 | 0.120 |
Why?
| Aortic Aneurysm, Abdominal | 1 | 2016 | 131 | 0.120 |
Why?
| Muscle Hypotonia | 1 | 2015 | 32 | 0.120 |
Why?
| Transglutaminases | 1 | 2015 | 154 | 0.120 |
Why?
| Prevalence | 2 | 2016 | 2541 | 0.120 |
Why?
| Forkhead Transcription Factors | 1 | 2016 | 182 | 0.120 |
Why?
| Contracture | 1 | 2015 | 24 | 0.120 |
Why?
| Hair | 1 | 2015 | 73 | 0.120 |
Why?
| Chromosomes, Human, Pair 16 | 2 | 2014 | 31 | 0.120 |
Why?
| Golgi Apparatus | 1 | 2015 | 100 | 0.120 |
Why?
| Autoantigens | 1 | 2017 | 414 | 0.120 |
Why?
| Sodium Channels | 1 | 2015 | 62 | 0.120 |
Why?
| Principal Component Analysis | 1 | 2015 | 187 | 0.120 |
Why?
| Moyamoya Disease | 1 | 2014 | 18 | 0.120 |
Why?
| Genetic Heterogeneity | 1 | 2014 | 55 | 0.120 |
Why?
| RNA Splicing | 1 | 2016 | 254 | 0.110 |
Why?
| Muscle, Smooth, Vascular | 2 | 2016 | 430 | 0.110 |
Why?
| Labyrinth Supporting Cells | 1 | 2014 | 3 | 0.110 |
Why?
| Arthritis | 1 | 2015 | 114 | 0.110 |
Why?
| Extremities | 1 | 2015 | 129 | 0.110 |
Why?
| Carrier Proteins | 2 | 2018 | 731 | 0.110 |
Why?
| Microsatellite Repeats | 3 | 2018 | 163 | 0.110 |
Why?
| Cyclic GMP-Dependent Protein Kinase Type I | 1 | 2013 | 2 | 0.110 |
Why?
| Transfer RNA Aminoacylation | 1 | 2013 | 2 | 0.110 |
Why?
| Fatty Acids | 1 | 2016 | 415 | 0.110 |
Why?
| Tetraspanins | 1 | 2013 | 15 | 0.110 |
Why?
| Aging, Premature | 1 | 2013 | 13 | 0.110 |
Why?
| Hair Cells, Auditory, Inner | 1 | 2013 | 14 | 0.110 |
Why?
| Face | 1 | 2015 | 168 | 0.110 |
Why?
| Leukoencephalopathies | 1 | 2013 | 20 | 0.110 |
Why?
| Computational Biology | 2 | 2018 | 588 | 0.110 |
Why?
| Biomarkers | 1 | 2024 | 3878 | 0.110 |
Why?
| Ubiquitin-Protein Ligases | 1 | 2014 | 156 | 0.110 |
Why?
| Cytoplasm | 1 | 2014 | 260 | 0.100 |
Why?
| Language Development Disorders | 1 | 2013 | 42 | 0.100 |
Why?
| Adaptor Proteins, Signal Transducing | 1 | 2016 | 395 | 0.100 |
Why?
| Chickens | 1 | 2013 | 188 | 0.100 |
Why?
| Cell Line | 1 | 2018 | 2762 | 0.100 |
Why?
| Sequence Deletion | 1 | 2013 | 180 | 0.100 |
Why?
| Neoplasm Proteins | 2 | 2017 | 428 | 0.100 |
Why?
| Proteins | 1 | 2018 | 945 | 0.100 |
Why?
| GPI-Linked Proteins | 1 | 2012 | 67 | 0.100 |
Why?
| Transforming Growth Factor beta2 | 1 | 2012 | 32 | 0.100 |
Why?
| Claudins | 1 | 2012 | 25 | 0.100 |
Why?
| Chromosomes, Human, Pair 7 | 1 | 2011 | 15 | 0.090 |
Why?
| Smad3 Protein | 1 | 2011 | 44 | 0.090 |
Why?
| Autoimmune Diseases | 1 | 2015 | 421 | 0.090 |
Why?
| Chromosomes, Human, Pair 1 | 1 | 2011 | 72 | 0.090 |
Why?
| Population Surveillance | 1 | 2014 | 428 | 0.090 |
Why?
| Quality of Life | 1 | 2023 | 2711 | 0.090 |
Why?
| Cross-Sectional Studies | 2 | 2016 | 5036 | 0.090 |
Why?
| Syndrome | 2 | 2015 | 343 | 0.090 |
Why?
| Chromosomes, Human, Pair 2 | 2 | 2013 | 28 | 0.090 |
Why?
| Aorta, Thoracic | 1 | 2013 | 260 | 0.090 |
Why?
| Logistic Models | 1 | 2016 | 1966 | 0.090 |
Why?
| Mitochondria | 1 | 2016 | 840 | 0.090 |
Why?
| Gene Expression Regulation | 1 | 2019 | 2523 | 0.080 |
Why?
| Epilepsy | 1 | 2014 | 315 | 0.080 |
Why?
| Heterozygote | 2 | 2014 | 269 | 0.080 |
Why?
| Software | 1 | 2014 | 612 | 0.080 |
Why?
| Lung Diseases, Interstitial | 1 | 2015 | 594 | 0.080 |
Why?
| DNA Mutational Analysis | 3 | 2017 | 391 | 0.080 |
Why?
| Signal Transduction | 2 | 2019 | 4867 | 0.070 |
Why?
| Audiometry | 2 | 2005 | 27 | 0.070 |
Why?
| Protein Domains | 2 | 2021 | 243 | 0.070 |
Why?
| Kelch-Like ECH-Associated Protein 1 | 1 | 2006 | 11 | 0.070 |
Why?
| Chromosomes, Human, Pair 20 | 1 | 2006 | 16 | 0.070 |
Why?
| Chromosomes, Human, Pair 12 | 1 | 2006 | 21 | 0.070 |
Why?
| Audiometry, Pure-Tone | 1 | 2006 | 26 | 0.070 |
Why?
| Jordan | 1 | 2005 | 3 | 0.060 |
Why?
| Auditory Threshold | 1 | 2006 | 38 | 0.060 |
Why?
| Sequence Analysis, Protein | 1 | 2005 | 29 | 0.060 |
Why?
| Chromosome Aberrations | 1 | 2006 | 148 | 0.060 |
Why?
| Risk Factors | 2 | 2016 | 9804 | 0.060 |
Why?
| Population Dynamics | 1 | 2006 | 135 | 0.060 |
Why?
| Chromosomes, Human, Pair 3 | 1 | 2005 | 48 | 0.060 |
Why?
| Netherlands | 1 | 2005 | 78 | 0.060 |
Why?
| Conserved Sequence | 1 | 2005 | 228 | 0.060 |
Why?
| Hypopituitarism | 1 | 2023 | 15 | 0.050 |
Why?
| Linear Models | 1 | 2006 | 818 | 0.050 |
Why?
| Membrane Glycoproteins | 1 | 2006 | 465 | 0.050 |
Why?
| Nuclear Proteins | 2 | 2018 | 644 | 0.050 |
Why?
| Gene Expression Regulation, Developmental | 2 | 2020 | 817 | 0.050 |
Why?
| Genome-Wide Association Study | 3 | 2016 | 1334 | 0.050 |
Why?
| United States | 1 | 2019 | 13992 | 0.050 |
Why?
| Calcium-Binding Proteins | 2 | 2014 | 213 | 0.050 |
Why?
| Sex Characteristics | 1 | 2006 | 724 | 0.040 |
Why?
| Evolution, Molecular | 1 | 2005 | 465 | 0.040 |
Why?
| Sequence Homology | 1 | 2020 | 40 | 0.040 |
Why?
| Aged | 4 | 2016 | 22068 | 0.040 |
Why?
| Fibroblasts | 2 | 2016 | 946 | 0.040 |
Why?
| Growth Disorders | 1 | 2020 | 78 | 0.040 |
Why?
| Movement Disorders | 1 | 2020 | 53 | 0.040 |
Why?
| Embryonic Development | 1 | 2020 | 118 | 0.040 |
Why?
| Nucleotide Mapping | 1 | 2018 | 3 | 0.040 |
Why?
| Ophthalmoscopy | 1 | 2018 | 32 | 0.040 |
Why?
| Disease Progression | 1 | 2006 | 2607 | 0.040 |
Why?
| Cells, Cultured | 2 | 2016 | 4063 | 0.040 |
Why?
| Sjogren-Larsson Syndrome | 1 | 2017 | 1 | 0.040 |
Why?
| Ichthyosis Vulgaris | 1 | 2017 | 1 | 0.040 |
Why?
| Porphyria, Variegate | 1 | 2017 | 1 | 0.040 |
Why?
| Protoporphyrinogen Oxidase | 1 | 2017 | 1 | 0.040 |
Why?
| Flavoproteins | 1 | 2017 | 8 | 0.040 |
Why?
| Photosensitivity Disorders | 1 | 2017 | 8 | 0.040 |
Why?
| INDEL Mutation | 1 | 2017 | 15 | 0.040 |
Why?
| 1-Acylglycerol-3-Phosphate O-Acyltransferase | 1 | 2017 | 3 | 0.040 |
Why?
| Epidermolysis Bullosa Simplex | 1 | 2017 | 10 | 0.040 |
Why?
| Keratin-14 | 1 | 2017 | 15 | 0.040 |
Why?
| Xeroderma Pigmentosum | 1 | 2017 | 7 | 0.040 |
Why?
| Lipid Metabolism, Inborn Errors | 1 | 2017 | 17 | 0.040 |
Why?
| Aldehyde Oxidoreductases | 1 | 2017 | 29 | 0.040 |
Why?
| Endonucleases | 1 | 2017 | 30 | 0.040 |
Why?
| Intermediate Filament Proteins | 1 | 2017 | 57 | 0.040 |
Why?
| Collagen Type VII | 1 | 2017 | 25 | 0.040 |
Why?
| Molecular Docking Simulation | 1 | 2018 | 108 | 0.040 |
Why?
| Blister | 1 | 2017 | 45 | 0.040 |
Why?
| DNA-Binding Proteins | 2 | 2017 | 1424 | 0.040 |
Why?
| Epidermolysis Bullosa Dystrophica | 1 | 2017 | 38 | 0.040 |
Why?
| Periodontal Diseases | 1 | 2017 | 62 | 0.030 |
Why?
| Muscular Diseases | 1 | 2017 | 110 | 0.030 |
Why?
| Epidermolysis Bullosa | 1 | 2017 | 59 | 0.030 |
Why?
| Genetic Complementation Test | 1 | 2016 | 63 | 0.030 |
Why?
| Stereocilia | 1 | 2016 | 8 | 0.030 |
Why?
| RNA, Messenger | 2 | 2014 | 2702 | 0.030 |
Why?
| Transcription Factors | 2 | 2017 | 1636 | 0.030 |
Why?
| Severity of Illness Index | 1 | 2005 | 2768 | 0.030 |
Why?
| Cameroon | 1 | 2016 | 8 | 0.030 |
Why?
| Physical Chromosome Mapping | 2 | 2006 | 17 | 0.030 |
Why?
| Basal Ganglia | 1 | 2016 | 51 | 0.030 |
Why?
| Chromosomes, Human, Pair 14 | 1 | 2015 | 18 | 0.030 |
Why?
| Mitochondrial Diseases | 1 | 2016 | 89 | 0.030 |
Why?
| Chromosomes, Human, Pair 17 | 1 | 2015 | 55 | 0.030 |
Why?
| Cataract | 1 | 2018 | 197 | 0.030 |
Why?
| Follow-Up Studies | 1 | 2005 | 4927 | 0.030 |
Why?
| Mitochondrial Proteins | 1 | 2017 | 235 | 0.030 |
Why?
| Cyclin-Dependent Kinase Inhibitor p21 | 1 | 2016 | 115 | 0.030 |
Why?
| Limit of Detection | 1 | 2015 | 57 | 0.030 |
Why?
| Craniofacial Dysostosis | 1 | 2015 | 3 | 0.030 |
Why?
| Genotyping Techniques | 1 | 2015 | 72 | 0.030 |
Why?
| Sequence Homology, Amino Acid | 1 | 2015 | 370 | 0.030 |
Why?
| Introns | 1 | 2016 | 242 | 0.030 |
Why?
| Hepatocyte Growth Factor | 1 | 2014 | 34 | 0.030 |
Why?
| Cloning, Molecular | 1 | 2016 | 536 | 0.030 |
Why?
| Gene Rearrangement | 1 | 2015 | 151 | 0.030 |
Why?
| Endoplasmic Reticulum Stress | 1 | 2015 | 98 | 0.030 |
Why?
| Ion Channels | 1 | 2015 | 126 | 0.030 |
Why?
| Alternative Splicing | 1 | 2016 | 216 | 0.030 |
Why?
| Myocytes, Smooth Muscle | 1 | 2016 | 246 | 0.030 |
Why?
| Vascular Remodeling | 1 | 2016 | 187 | 0.030 |
Why?
| Sample Size | 1 | 2014 | 117 | 0.030 |
Why?
| Adenosine Triphosphatases | 1 | 2014 | 164 | 0.030 |
Why?
| GTPase-Activating Proteins | 1 | 2014 | 82 | 0.030 |
Why?
| Myosin Light Chains | 1 | 2013 | 27 | 0.030 |
Why?
| Odds Ratio | 1 | 2016 | 1021 | 0.030 |
Why?
| Protein Transport | 1 | 2015 | 424 | 0.030 |
Why?
| Cyclic GMP | 1 | 2013 | 85 | 0.030 |
Why?
| Disease | 1 | 2014 | 95 | 0.030 |
Why?
| Aorta | 1 | 2016 | 410 | 0.030 |
Why?
| Osteogenesis | 1 | 2015 | 190 | 0.030 |
Why?
| Retina | 1 | 2015 | 277 | 0.030 |
Why?
| Heart Valve Diseases | 1 | 2014 | 170 | 0.030 |
Why?
| Endoplasmic Reticulum | 1 | 2015 | 257 | 0.030 |
Why?
| Saccharomyces cerevisiae | 1 | 2016 | 517 | 0.030 |
Why?
| Genome, Human | 1 | 2014 | 393 | 0.020 |
Why?
| Data Interpretation, Statistical | 1 | 2014 | 337 | 0.020 |
Why?
| Haploinsufficiency | 1 | 2012 | 47 | 0.020 |
Why?
| Tumor Suppressor Protein p53 | 1 | 2016 | 510 | 0.020 |
Why?
| Ribose-Phosphate Pyrophosphokinase | 1 | 2011 | 1 | 0.020 |
Why?
| Age of Onset | 1 | 2013 | 494 | 0.020 |
Why?
| rac1 GTP-Binding Protein | 1 | 2011 | 55 | 0.020 |
Why?
| Chromosomes, Human, Pair 21 | 1 | 2011 | 39 | 0.020 |
Why?
| Neuropeptides | 1 | 2011 | 70 | 0.020 |
Why?
| Models, Genetic | 1 | 2013 | 588 | 0.020 |
Why?
| Aortic Valve | 1 | 2014 | 425 | 0.020 |
Why?
| Gene Expression | 1 | 2016 | 1477 | 0.020 |
Why?
| Muscle Contraction | 1 | 2013 | 426 | 0.020 |
Why?
| Computer Simulation | 1 | 2013 | 943 | 0.020 |
Why?
| Glycoproteins | 1 | 2011 | 340 | 0.020 |
Why?
| Actins | 1 | 2011 | 405 | 0.020 |
Why?
| Trans-Activators | 1 | 2011 | 387 | 0.020 |
Why?
| Protein Structure, Tertiary | 1 | 2011 | 835 | 0.020 |
Why?
| Cell Cycle Proteins | 1 | 2011 | 576 | 0.020 |
Why?
| Retrospective Studies | 1 | 2005 | 14562 | 0.020 |
Why?
| Apoptosis | 1 | 2016 | 2485 | 0.020 |
Why?
| Promoter Regions, Genetic | 1 | 2011 | 1195 | 0.020 |
Why?
| India | 1 | 2006 | 167 | 0.020 |
Why?
| Magnetic Resonance Imaging | 1 | 2013 | 3357 | 0.010 |
Why?
| Brain | 1 | 2013 | 2604 | 0.010 |
Why?
|
|
Santos-Cortez's Networks
Click the "See All" links for more information and interactive visualizations!
Concepts  Derived automatically from this person's publications. _
Co-Authors  People in Profiles who have published with this person. _
Similar People  People who share similar concepts with this person. _
Same Department
People who are also in this person's primary department.
Physical Neighbors  People whose addresses are nearby this person. _
|